This Week at AVAC: US election, new LEN resources, STI pipeline and PrEP service delivery
View this email in your browser ([link removed])
[link removed] November 12, 2024
** US election, new LEN resources, STI pipeline, PrEP service delivery and more
------------------------------------------------------------
Dear Advocate,
As we continue to grapple with the results ([link removed]) of the US presidential election and what this means for our work and for global health evidence- and rights-based policies and programs generally, we wanted to share a range of new tools and resources you may find helpful in your advocacy for choice, science and rights.
Injectable Lenacapavir for PrEP
Webinar
Save the Date
[link removed]
Register ([link removed]) [link removed]
[link removed]
Reel
Choice Not Miracles
** Choice, Not Miracles.
------------------------------------------------------------
AVAC Communications Director, Kenyon Farrow ([link removed]) breaks down the potential of LEN to make choice a reality.
View on Instagram [link removed]
Additional LEN Resources
• Report: From Clinical Trial Efficacy to Public Health Impact: A Plan for Accelerating Access to Injectable Lenacapavir for PrEP ([link removed])
• PxPulse Podcast Lenacapavir: The case for investing in delivering HIV prevention ([link removed])
• Advocates' Guide: The Lens on LEN: The Basics on Injectable Lenacapavir as PrEP ([link removed])
• Graphic: An Overview of Lenacapavir for PrEP Trials ([link removed])
• Graphic: Moving a Product to the Real World ([link removed])
• Recording: Breaking New Ground: Expanding Access to Lenacapavir—Lessons from Dolutegravir and the Future of HIV Prevention ([link removed])
• Graphic: The Future of ARV-Based Prevention and More ([link removed])
• See our lenacapavir page ([link removed]) for a full suite of resources
Webinars on the STI Pipeline, Advances in Research Ethics, and Money for the DVR and More!
Upcoming webinar
November 14 @ 8:00am EST
[link removed]
Register Now ([link removed]) [link removed]
Upcoming webinar
November 19, 2024 @ 9:30am EST/17:30 EAT
[link removed]
Register Now ([link removed]) [link removed]
Webinar Recording
Launch of CIFF/Global Fund Initiative for the PrEP Ring
** Recording ([link removed]) / Slides ([link removed]) / DVR Early Market Access Vehicle page ([link removed])
------------------------------------------------------------
This webinar helped kick-off the launch of the PrEP Ring Early Market Access Vehicle (EMAV), recently announced by CIFF in partnership with the Global Fund. This initiative will provide up to US$2 million to purchase up to 150,000 dapivirine vaginal rings in countries implementing Global Fund HIV grants.
[link removed]
in case you missed it
** PxWire, Volume 14, Issue 4
------------------------------------------------------------
The latest PxWire discusses the newest trends in global PrEP uptake, what we can expect from lenacapavir, what's on the R&D prevention pipeline and a roundup of useful resources.
read the full issue ([link removed]) [link removed]
And stay tuned for a new PxPulse podcast featuring Jen Kates ([link removed]) of KFF and AVAC’s Suraj Madoori ([link removed]) , The Votes Are In: What’s next for the US’ role in global health and HIV prevention ([link removed]) . The podcast hits airways November 14.
Best,
AVAC
Follow us @hivpxresearch ([link removed])
[link removed] [link removed] [link removed]
Share this issue ([link removed]) [link removed]
AVAC Global Advocacy for HIV Prevention
+1 212 796 6423
[email protected] (mailto:
[email protected]) www.avac.org ([link removed])
You're receiving this because you signed up for our newsletter. Not interested any longer?
Manage email preferences ([link removed]) | Unsubscribe ([link removed])
